346 related articles for article (PubMed ID: 23199607)
1. Blockade of peanut allergy with a novel Ara h 2-Fcγ fusion protein in mice.
Liu Y; Sun Y; Chang LJ; Li N; Li H; Yu Y; Bryce PJ; Grammer LC; Schleimer RP; Zhu D
J Allergy Clin Immunol; 2013 Jan; 131(1):213-21.e1-5. PubMed ID: 23199607
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy using algal-produced Ara h 1 core domain suppresses peanut allergy in mice.
Gregory JA; Shepley-McTaggart A; Umpierrez M; Hurlburt BK; Maleki SJ; Sampson HA; Mayfield SP; Berin MC
Plant Biotechnol J; 2016 Jul; 14(7):1541-50. PubMed ID: 26801740
[TBL] [Abstract][Full Text] [Related]
3. The 2S albumin allergens of Arachis hypogaea, Ara h 2 and Ara h 6, are the major elicitors of anaphylaxis and can effectively desensitize peanut-allergic mice.
Kulis M; Chen X; Lew J; Wang Q; Patel OP; Zhuang Y; Murray KS; Duncan MW; Porterfield HS; W Burks A; Dreskin SC
Clin Exp Allergy; 2012 Feb; 42(2):326-36. PubMed ID: 22288514
[TBL] [Abstract][Full Text] [Related]
4. Ara h 6 complements Ara h 2 as an important marker for IgE reactivity to peanut.
Koid AE; Chapman MD; Hamilton RG; van Ree R; Versteeg SA; Dreskin SC; Koppelman SJ; Wünschmann S
J Agric Food Chem; 2014 Jan; 62(1):206-13. PubMed ID: 24328145
[TBL] [Abstract][Full Text] [Related]
5. Ara h 2: crystal structure and IgE binding distinguish two subpopulations of peanut allergic patients by epitope diversity.
Mueller GA; Gosavi RA; Pomés A; Wünschmann S; Moon AF; London RE; Pedersen LC
Allergy; 2011 Jul; 66(7):878-85. PubMed ID: 21255036
[TBL] [Abstract][Full Text] [Related]
6. Targeting Ara h 2 with human-derived monoclonal antibodies prevents peanut-induced anaphylaxis in mice.
Paolucci M; Wuillemin N; Homère V; Bieli D; Köhli A; Ballmer-Weber B; Waeckerle-Men Y; Pengo N; Kündig TM; Sonati T; Johansen P
Allergy; 2023 Jun; 78(6):1605-1614. PubMed ID: 36704937
[TBL] [Abstract][Full Text] [Related]
7. Expression of a codon-optimised recombinant Ara h 2.02 peanut allergen in Escherichia coli.
Lew MH; Lim RL
Appl Microbiol Biotechnol; 2016 Jan; 100(2):661-71. PubMed ID: 26411458
[TBL] [Abstract][Full Text] [Related]
8. An unfolded variant of the major peanut allergen Ara h 2 with decreased anaphylactic potential.
Starkl P; Felix F; Krishnamurthy D; Stremnitzer C; Roth-Walter F; Prickett SR; Voskamp AL; Willensdorfer A; Szalai K; Weichselbaumer M; O'Hehir RE; Jensen-Jarolim E
Clin Exp Allergy; 2012 Dec; 42(12):1801-12. PubMed ID: 23181796
[TBL] [Abstract][Full Text] [Related]
9. Effect of roasting on the allergenicity of major peanut allergens Ara h 1 and Ara h 2/6: the necessity of degranulation assays.
Vissers YM; Iwan M; Adel-Patient K; Stahl Skov P; Rigby NM; Johnson PE; Mandrup Müller P; Przybylski-Nicaise L; Schaap M; Ruinemans-Koerts J; Jansen AP; Mills EN; Savelkoul HF; Wichers HJ
Clin Exp Allergy; 2011 Nov; 41(11):1631-42. PubMed ID: 21801247
[TBL] [Abstract][Full Text] [Related]
10. Lactobacillus buchneri S-layer as carrier for an Ara h 2-derived peptide for peanut allergen-specific immunotherapy.
Anzengruber J; Bublin M; Bönisch E; Janesch B; Tscheppe A; Braun ML; Varga EM; Hafner C; Breiteneder H; Schäffer C
Mol Immunol; 2017 May; 85():81-88. PubMed ID: 28212503
[TBL] [Abstract][Full Text] [Related]
11. A murine model of peanut anaphylaxis: T- and B-cell responses to a major peanut allergen mimic human responses.
Li XM; Serebrisky D; Lee SY; Huang CK; Bardina L; Schofield BH; Stanley JS; Burks AW; Bannon GA; Sampson HA
J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):150-8. PubMed ID: 10887318
[TBL] [Abstract][Full Text] [Related]
12. 2S protein Ara h 7.0201 has unique epitopes compared to other Ara h 7 isoforms and is comparable to 2S proteins Ara h 2 and 6 in basophil degranulation capacity.
Hayen SM; Ehlers AM; den Hartog Jager CF; Garssen J; Knol EF; Knulst AC; Suer W; Willemsen LEM; Otten HG
Clin Exp Allergy; 2018 Jul; 48(7):890-897. PubMed ID: 29542223
[TBL] [Abstract][Full Text] [Related]
13. Effect of chemical modifications on allergenic potency of peanut proteins.
Bencharitiwong R; van der Kleij HP; Koppelman SJ; Nowak-Węgrzyn A
Allergy Asthma Proc; 2015; 36(3):185-91. PubMed ID: 25976435
[TBL] [Abstract][Full Text] [Related]
14. Effector activity of peanut allergens: a critical role for Ara h 2, Ara h 6, and their variants.
Porterfield HS; Murray KS; Schlichting DG; Chen X; Hansen KC; Duncan MW; Dreskin SC
Clin Exp Allergy; 2009 Jul; 39(7):1099-108. PubMed ID: 19438581
[TBL] [Abstract][Full Text] [Related]
15. The non-specific lipid transfer protein, Ara h 9, is an important allergen in peanut.
Lauer I; Dueringer N; Pokoj S; Rehm S; Zoccatelli G; Reese G; Miguel-Moncin MS; Cistero-Bahima A; Enrique E; Lidholm J; Vieths S; Scheurer S
Clin Exp Allergy; 2009 Sep; 39(9):1427-37. PubMed ID: 19624524
[TBL] [Abstract][Full Text] [Related]
16. Conformational IgE epitopes of peanut allergens Ara h 2 and Ara h 6.
Chen X; Negi SS; Liao S; Gao V; Braun W; Dreskin SC
Clin Exp Allergy; 2016 Aug; 46(8):1120-1128. PubMed ID: 27238146
[TBL] [Abstract][Full Text] [Related]
17. Enhanced Prophylactic and Therapeutic Effects of Polylysine-Modified Ara h 2 DNA Vaccine in a Mouse Model of Peanut Allergy.
Zhu Z; Yu J; Niu Y; Sun S; Liu Y; Saxon A; Zhang K; Li W
Int Arch Allergy Immunol; 2016; 171(3-4):241-250. PubMed ID: 28049187
[TBL] [Abstract][Full Text] [Related]
18. Capacity of purified peanut allergens to induce degranulation in a functional in vitro assay: Ara h 2 and Ara h 6 are the most efficient elicitors.
Blanc F; Adel-Patient K; Drumare MF; Paty E; Wal JM; Bernard H
Clin Exp Allergy; 2009 Aug; 39(8):1277-85. PubMed ID: 19538351
[TBL] [Abstract][Full Text] [Related]
19. Ara h 2 and Ara h 6 have similar allergenic activity and are substantially redundant.
Chen X; Wang Q; El-Mezayen R; Zhuang Y; Dreskin SC
Int Arch Allergy Immunol; 2013; 160(3):251-8. PubMed ID: 23075924
[TBL] [Abstract][Full Text] [Related]
20. Early decrease in basophil sensitivity to Ara h 2 precedes sustained unresponsiveness after peanut oral immunotherapy.
Patil SU; Steinbrecher J; Calatroni A; Smith N; Ma A; Ruiter B; Virkud Y; Schneider M; Shreffler WG
J Allergy Clin Immunol; 2019 Nov; 144(5):1310-1319.e4. PubMed ID: 31377342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
